Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Ferrè

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Brain Communications|August 2, 2024
Reduction of sacsin levels in peripheral blood mononuclear cells as a diagnostic tool for spastic ataxia of Charlevoix-SaguenayDaniele De Ritis, Laura Ferrè, Jonathan De Winter, et al.
Genes|November 11, 2022
Involvement of NINJ2 Protein in Inflammation and Blood-Brain Barrier Transmigration of Monocytes in Multiple SclerosisMelissa Sorosina, Silvia Peroni, Elisabetta Mascia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2015
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric studyLaura Ferrè, Arturo Nuara, Giulia Pavan, et al.
Journal of Personalized Medicine|January 21, 2023
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine ApproachLaura Ferrè, Ferdinando Clarelli, Beatrice Pignolet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2024
Vitamin D affects the risk of disease activity in multiple sclerosisAntonino Giordano, Ferdinando Clarelli, Béatrice Pignolet, et al.
Molecular Neurobiology|June 8, 2024
Genetic Contribution to Medium-Term Disease Activity in Multiple SclerosisElisabetta Mascia, Valentina Nale, Laura Ferrè, et al.
Multiple Sclerosis and Related Disorders|July 3, 2020
Impact of multiple sclerosis risk loci in postinfectious neurological syndromesFilippo Martinelli-Boneschi, Riccardo Currò, Silvia Santoro, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2019
A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosisSilvia Peroni, Melissa Sorosina, Sunny Malhotra, et al.
Journal of Neurology|May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Brain Communications|August 2, 2024
Reduction of sacsin levels in peripheral blood mononuclear cells as a diagnostic tool for spastic ataxia of Charlevoix-SaguenayDaniele De Ritis, Laura Ferrè, Jonathan De Winter, et al.
Genes|November 11, 2022
Involvement of NINJ2 Protein in Inflammation and Blood-Brain Barrier Transmigration of Monocytes in Multiple SclerosisMelissa Sorosina, Silvia Peroni, Elisabetta Mascia, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 18, 2015
Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric studyLaura Ferrè, Arturo Nuara, Giulia Pavan, et al.
Journal of Personalized Medicine|January 21, 2023
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine ApproachLaura Ferrè, Ferdinando Clarelli, Beatrice Pignolet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 14, 2024
Vitamin D affects the risk of disease activity in multiple sclerosisAntonino Giordano, Ferdinando Clarelli, Béatrice Pignolet, et al.
Molecular Neurobiology|June 8, 2024
Genetic Contribution to Medium-Term Disease Activity in Multiple SclerosisElisabetta Mascia, Valentina Nale, Laura Ferrè, et al.
Multiple Sclerosis and Related Disorders|July 3, 2020
Impact of multiple sclerosis risk loci in postinfectious neurological syndromesFilippo Martinelli-Boneschi, Riccardo Currò, Silvia Santoro, et al.
Acta Neurologica Scandinavica|July 24, 2018
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment responseMarzia A L Romeo, Vittorio Martinelli, Gloria Dalla Costa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2019
A pharmacogenetic study implicates <i>NINJ2</i> in the response to Interferon-β in multiple sclerosisSilvia Peroni, Melissa Sorosina, Sunny Malhotra, et al.
Journal of Neurology|May 11, 2022
A multi-step genomic approach prioritized TBKBP1 gene as relevant for multiple sclerosis susceptibilityMelissa Sorosina, Nadia Barizzone, Ferdinando Clarelli, et al.
Pageof 3